Thrombolysis of Urokinase for Minor Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1005 participants.
Also called NCT04420351
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,005 participants
- Sponsor
- Registry
-
NCT04420351
-
- Other papers using this trial's data
- Effect of intravenous urokinase vs best medicine treatment on functional outcome for patients with acute minor stroke (TRUST): a randomized controlled trial
- Efficacy and safety of urokinase intravenous thrombolysis in minor stroke according to large vessel occlusion status: a subgroup analysis of the TRUST trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT04420351. Randomized; single masking; primary purpose treatment. Start 2020-10-04 (actual); primary completion 2023-02-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Thrombolysis of Urokinase for Minor Stroke
- Acronym
- TRUST
- Condition
- Minor Stroke
- Intervention (Drug)
- Urokinase thrombolysis
- Intervention (Drug)
- Aspirin;Clopidogrel
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou University
- Collaborator
- Beijing Tiantan Hospital
- Collaborator
- Shanghai 10th People's Hospital
- Collaborator
- General Hospital of Shenyang Military Region
Record details
- Record id
cardio:ct-nct04420351- Content hash
38c5b389ba59598b3a6bf497e339f5fc79698bb11c5bbfd3764a57bca10dd0b3